Objective-Body iron status has been linked to atherosclerosis in adults. The purposes of our study were to determine (1) the association between circulating ferritin levels and carotid intima-media thickness (cIMT) in a cohort of apparently healthy children and (2) the association between cIMT and parental ferritin levels. Approach and Results-Circulating ferritin levels (microparticle enzyme immunoassay), metabolic parameters, and cIMT (ultrasonography) were analyzed cross-sectionally in a cohort of 692 healthy white children with a mean age of 8±2 years (52% girls and 48% boys). In consecutive 123 children from the cross-sectional sample, the same serum assessments were also performed at baseline in their parents, and the cIMT was repeated after 3 years of follow-up in the children at a mean age of 11±2 years (53% girls and 47% boys). Weak but significant positive associations were evident between children's circulating ferritin levels and cIMT (r=0.123; P=0.001) and with the change in cIMT 3 years later a tendency was also observed (r=0.185; P=0.048). In multiple regression analyses, circulating ferritin levels contributed independently to cIMT variance (β=0.090; P=0.026; R 2 =10%) and cIMT change variance (β=0.216; P=0.019; R 2 = 3.4%) after controlling for body mass index, high-sensitivity C-reactive protein, age, sex, and low-density lipoprotein-cholesterol levels. This association was, however, remarkably significant (β=0.509; P=0.001; R 2 = 20.4%) in children whose fathers had ferritin levels above the median value (122.5 ng/mL).The latter association remained significant after correction for multiple testing. Maternal's ferritin levels showed no interaction in this association.
C ardiovascular disease (CVD) is the leading cause of death globally: more people die annually from CVD than from any other cause. 1 CVD is extremely rare in children; however, there is a growing interest in the identification of cardiovascular risk factors at an early stage of life because they have long-term effects on vascular health.
Body iron status has been linked to chronic diseases with particular emphasis on atherosclerosis, metabolic syndrome, and diabetes mellitus. Evidences of the effects of iron status on the risk of coronary heart disease were first proposed by Sullivan 2 in the 1980s, in the iron hypothesis. This theory defends that overload promotes CVD, whereas, on the contrary, sustained iron depletion/deficiency exerts a primary protective effect against ischemic heart disease. Since then, several epidemiological studies have investigated the association between iron stores and the carotid intima-media thickness (cIMT). [3] [4] [5] [6] In 2007, in his refined iron hypothesis, Sullivan 7 proposed that hepcidin might increase CVD risk by trapping iron into macrophages within the plaque, promoting transformation of these cells into foam cells becoming an atherosclerosis promoter.
In an epidemiological study conducted in the general population, Galesloot et al 8 demonstrated that serum hepcidin and its ratio to ferritin are associated with atherosclerosis, especially in postmenopausal women. In this line, ferritin was considered an independent predictor of vascular damage in patients with nonalcoholic fatty liver disease, and the mechanism may involve upregulation of hepcidin by increased iron stores. 9 This fact was also proved in ex vivo experiments in which treatment with iron salts or hepcidin of human differentiating monocytes induces proinflammatory cytokines release. 10 However, the inconsistent effects of iron in atherosclerotic mouse models do not support the hypothesis that iron is an important aggravating factor in the pathogenesis of atherosclerosis. 11 The relationship between iron stores and cIMT has also been reported in children with end-stage renal disease 12 and with β-thalassemia. [13] [14] [15] It is important to note that these reports have indicated that the association between ferritin and cIMT is also observed in apparently healthy children; however, given the low number of subjects studied (n=22), these results may only be considered as preliminary. 12 The intrafamilial aggregation of flow-mediated vascular dilation has been shown to be significantly higher in fatheroffspring than in mother-offspring, placing these children at higher risk for CVD. 16 Indeed, the presence of familial metabolic risk factors is known to predict future cardiovascular events in the offspring. 17, 18 It is well known that increased cIMT is an independent risk marker for coronary artery disease and stroke, becoming a sensitive subclinical atherosclerosis marker. 19 Given the associations found in adults and in children with iron overload, we hypothesized that serum ferritin levels could be linked to cIMT in children from the general population. The purposes of our study were to evaluate (1) the possible association between circulating ferritin levels and cIMT in a cohort of apparently healthy children and (2) the possible relationship between parental ferritin levels and cIMT in the children.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Results for clinical, vascular, and metabolic parameters are shown in Table 1 for all the studied children (n=692; 333 girls and 359 boys) included in the cross-sectional study and in Table I in the online-only Data Supplement for all children included in the longitudinal study (n=123; 65 girls and 58 boys; Figure 1 ). Results are shown according to sex. At baseline, boys were slightly older and had higher fasting glucose levels and lower diastolic blood pressure and triglycerides (all P<0.01).
In the complete sample of children, higher levels of ferritin were associated with higher cIMT values (r=0.123; P=0.001) and with the change in cIMT after 3 years of follow-up a tendency was also observed (r=0.185; P=0.048; Figure 2 ; Table II in the online-only Data Supplement). Children's ferritin levels also showed a tendency with father's ferritin (r=0.171; P=0.015) and were associated with mother's ferritin levels (r=0.231; P<0.0001; Figure II and Table II in the online-only Data Supplement). Notably, father's ferritin levels were associated with the change in cIMT on follow-up (r=0.207; P=0.022; Figure 3 ; Table II in the online-only Data Supplement) although this association did not remain significant after correcting for multiple testing. Furthermore, in children's whose fathers had circulating ferritin levels above the median for men (122.5 ng/mL), the association between children's ferritin and the change in cIMT was remarkably significant (r=0.520; P<0.0001; Figure 4 ). Children's ferritin levels were also associated with other iron markers such as transferrin (r=−0.202; P<0.0001) and transferrin saturation (r=−0.207; P<0.0001), as well as with body mass index z-score (r=0.220; P<0.0001) and high-sensitivity C-reactive protein (hsCRP; r=0.283; P<0.0001; Table II in the onlineonly Data Supplement). However, none of these variables showed significant associations with change in carotid IMT.
In multiple regression analyses, children's circulating ferritin levels contributed independently to cIMT variance at baseline (β=0.090; P=0.026) and the change of cIMT on follow-up (β=0.216; P=0.019; R 2 =3.4%) after controlling for age, sex, low-density lipoprotein-cholesterol, hsCRP, and body mass index (Table 2 ). Moreover, in children whose fathers had ferritin levels >122.5 ng/mL, the associations between children's ferritin levels and cIMT were remarkably significant (β=0.509; P=0.001; R 2 =20.4%) in multivariate regression analysis after adjustment for the abovementioned confounding variables: age, sex, low-density lipoprotein-cholesterol, hsCRP, and body mass index ( Table 3 ). The latter association remained significant after correction for multiple testing.
Discussion
The findings of the present study indicate that circulating ferritin levels associate with cIMT and change in cIMT in healthy children; furthermore, the association between children's ferritin and the change in cIMT was remarkably significant in those children whose fathers have higher ferritin levels.
Body iron stores have been involved in the development of atherosclerotic CVD. In the iron hypothesis, proposed by Sullivan, 2 the effects of iron status on the risk of coronary heart disease were demonstrated. This theory defends that overload promotes CVD, whereas sustained iron depletion/ deficiency exerts a protective effect against ischemic heart disease. In 1994, Kiechl et al 3 provided the first information about the relationship between carotid atherosclerosis, sonographically assessed, and ferritin levels. In a cross-sectional study that included 72 healthy men, the plasma-circulating transferrin receptor concentration:plasma ferritin concentration ratio was an independent contributor of cIMT after controlling for traditional risk factors of atherosclerosis. 4 In the Atherosclerosis Risk in Communities (ARIC) study using a matched case-control design, the odds ratio for cases with cIMT versus controls was 1.12 (95% confidence interval, 0.97-1.30). However, there was no association when major cardiovascular risk factors were considered. 5 In this sense, in a cohort of 2443 participants, Wolff et al 6 have reported that serum ferritin levels were not independently associated with cIMT among women or men, despite being associated with carotid plaque prevalence among men.
The underlying mechanism linking iron stores and CVD is not completely understood. However, it has been proposed that increased hepcidin may be responsible for iron-induced atherogenesis. This protein inhibits iron release from enterocytes and macrophages by degrading the iron exporter ferroportin. to promote atherosclerosis in mice. Iron might be effectively chaperoned in macrophages by ferritin. 11 Notwithstanding, this study could not exclude the possibility that hepcidin is locally increased in macrophages and adipocytes in the plaque environment and may promote macrophage iron accumulation locally. 11 On the contrary, Saeed et al 20 reported that pharmacological suppression of hepcidin synthesis through inhibition of the BMP (bone morphogenetic protein) pathway decreased atherosclerosis in another mice model. Furthermore, there is a debate whether it is the absolute amount of iron or the distribution of iron in the body that plays a role in the development of atherosclerosis. A small recent study showed that Fe(III) distribution varies substantially within atherosclerotic plaques. Plaques from symptomatic patients had significantly higher concentrations of Fe(III), signs of cap rupture and increased cap macrophage activity. 21 Recent results also suggested that the body iron distribution, as determined by hepcidin, affected the development of atherosclerosis in women. Hepcidin and the hepcidin/ferritin ratio, reflecting hepcidin expression relative to iron stores, were significantly associated with the presence of plaque in women (adjusted odds ratios for quartile 4 versus quartile 1 [95% confidence intervals], 3.07 [1.36-6.90] and 2.31 [1.03-5.18], respectively). The hepcidin/ferritin ratio was significantly and negatively associated with ankle-brachial index at rest in men and women (adjusted β for quartile 4 versus quartile 1 [95% confidence intervals], −0.03 [−0.07 to 0.00] and −0.04 [−0.06 to −0.01], respectively). 8 The relationship between iron stores and cIMT was already reported in children with kidney damage 12 and with β-thalassemia. [13] [14] [15] The mechanism proposed for this connection includes enhanced platelet activation, low-density lipoprotein oxidation, macrophage activity stimulation, and increased nitric oxide destruction in the context of oxidative stress and hemolysis. [22] [23] [24] [25] [26] As far as we know, this is the first report showing, in a large sample of healthy white children, that higher circulating ferritin levels are significantly associated with both cIMT and the change in cIMT on follow-up in apparently healthy children. Although the relationship between exposures to biochemical risk factors and IMT was already reported in adults with CVD and children with inherited metabolic diseases, [12] [13] [14] [15] A B data on this relationship in healthy children were lacking. In this sense, data yielded from our study support the association between iron stores and cIMT in a large cohort of healthy prepubertal children, suggesting that circulating ferritin levels may help to identify children at high risk for CVD. Our results also showed a positive association between children's ferritin levels and both father's and mother's ferritin levels. However, only fathers have an effect on the association between children's cIMT and children's ferritin levels. A previous study showed that ferritin, heavy polypeptide-like 17 (FTH117) gene, which encodes a protein involved in iron metabolism, is an imprinted gene predominantly expressed from the paternal allele. 27 Taken together, these results suggest a possible parental-specific effect on cIMT partially reflected by father's ferritin levels. It may be speculated that higher ferritin levels in fathers may reflect iron accumulation that could influence methylation of genes involved in iron metabolism. The presence of familial metabolic risk factors is known to predict future cardiovascular events in the offspring. 17, 18 However, the intrafamilial aggregation of flowmediated vascular dilation has been shown to be significantly higher in father-offsprings than in mother-offsprings. 16 It is known that high-density lipoprotein-cholesterol levels are a determinant of flow-mediated vascular dilation and are associated with genetic variation in the Y chromosome. 28 Moreover, it has been postulated that the menstrual cycle could influence endothelial function, 29, 30 and this could explain the lack of association between children's ferritin levels and cIMT according to maternal's ferritin levels and reinforce the idea of a paternal-specific effect on the association between ferritin levels and cIMT. The relationship between ferritin and hsCRP is of note reinforcing the inflammatory side of serum ferritin concentration. Ferritin is increased in conditions associated with inflammation because, in fact, it is an acute-phase reactant, 31 even in the presence of true iron deficiency. 32 Indeed, it has been considered that hsCRP measurement should be used to adjust for ferritin concentrations. 33, 34 However, we have found that the relationship between cIMT and serum ferritin persists even after adjusting for hsCRP. The lack of association with transferrin saturation could be because of the relatively short range of transferrin saturation in children.
We acknowledge the limitations of our study. The Food and Drug Administration has approved cIMT as a marker of atherosclerosis in adults. 35 However, there is no consensus on noninvasive methods of assessing atherosclerosis in children. 36 Dynamic studies such as direct assessment of endothelial function in children should be performed in future studies. It would be worth evaluating the relationship between iron stores and other atherosclerosis markers such as pulse-wave velocity (a clinical measure of stiffness over an arterial segment 37 or anklebrachial index [a surrogate marker for systemic atherosclerosis]). 38 Residual confounding by imperfectly or unmeasured variables cannot be excluded. Another possible limitation is that the study population was apparently healthy and needs to be confirmed in, for instance, children with CVD. The relatively small number of subjects included in the longitudinal study warrants further investigation, including replication studies in other populations, to validate current findings. Finally, the facts that the study relies on 1 measurement of ferritin concentration and that HFE (hemochromatosis) gene variant status was not available are also limitation of the current study.
In summary, we herein suggest a paternal-specific effect on the associations between children's ferritin levels and cIMT because the association is dependent on the sex of the parent. More studies, however, are needed to clarify the nature of this association. Ferritin levels may become a marker of cIMT in healthy children, and in particular, in those children whose father's have higher levels of ferritin. shows the combined effect of the independent variables. Nonpredictive variables: age, sex, body mass index, high-sensitivity C-reactive protein, systolic blood pressure, triglycerides, and low-density lipoprotein-cholesterol. IMT indicates intima-media thickness.
